Trevor Papkov is an accomplished Rare Disease Account Executive at Biogen since October 2023, following a successful tenure at Xeris Pharmaceuticals, where Trevor achieved President’s Club status in 2020 and ranked 4th nationally in total TRx in 2021. Prior experience includes various roles at Eli Lilly, notably as a Specialty Diabetes Representative and Growth Hormone Specialty Sales Consultant, demonstrating a strong ability to coach, manage projects, and lead teams. Earlier career positions at Pfizer as a Neuroscience Senior Specialty Sales Consultant included multiple accolades, such as the District Representative of the Semester in 2004 and being recognized among the top representatives nationally. Trevor holds a Bachelor of Arts in Biological Sciences from the University at Buffalo, with additional accomplishments highlighted by a consistent record of exceeding sales goals and receiving recognition in competitive environments.
This person is not in any teams
This person is not in any offices